,for, Item ID-
  • #1254858
  • Microgenics #10016433

Toxicology Reagent CEDIA® Cannabinoids (THC) CLIA Non-Waived For Clinical Chemistry Analyzers

REAGENT, IMMUNOASSAY CEDIA THCCANNABINOID INDIKO 3X17ML D/S

No Image

Features

  • The CEDIA THC Assay is an in-vitro diagnostic medical device intended for the qualitative and semiquantitative determination of cannabinoids (THC) in human urine
  • The CEDIA Multi-Level THC assay uses recombinant DNA technology (US Patent No. 4708929) to produce a unique homogeneous enzyme immunoassay system
  • Qualitative or semi-quantitative options for results
  • More …
Volume
3 X 17 mL 65 mL 495 mL
  Log In to Order
or

Product Specifications


Features
  • The CEDIA THC Assay is an in-vitro diagnostic medical device intended for the qualitative and semiquantitative determination of cannabinoids (THC) in human urine
  • The CEDIA Multi-Level THC assay uses recombinant DNA technology (US Patent No. 4708929) to produce a unique homogeneous enzyme immunoassay system
  • Qualitative or semi-quantitative options for results
  • Excellent correlation to GC/MS

Professionals Also Viewed